Why the study?
This study reports the first documented case of familial LVNC associated with the MYH7 p.Asp461Asn variant and assesses phenotypic variability among affected family members to identify contributors to clinical heterogeneity.
This report provides the first documented evidence linking the MYH7 p.Asp461Asn variant to familial left ventricular noncompaction cardiomyopathy, expanding the known genetic spectrum of the disease.
May inform genetic counseling for MYH7 p.Asp461Asn carriers in LVNC families; extends known genetic spectrum as first reported link.
Left ventricular noncompaction cardiomyopathy (LVNC) is a distinct form of cardiomyopathy that may present as either an inherited or a sporadic condition. This report describes the first documented case of familial LVNC associated with the MYH7 p.Asp461Asn variant. Phenotypic variability among affected individuals within the family was assessed to identify potential contributors to the observed clinical heterogeneity in LVNC. The reported family included 10 individuals across three generations. Two members were diagnosed with LVNC, and 1 was classified as having suspected LVNC. Identical twins (Ⅱ-1 and Ⅱ-3) were both found to harbor the heterozygous missense variant c.1381G > A (p.Asp461Asn) in the MYH7 gene. Subsequent pedigree analysis confirmed the presence of this variant in individuals Ⅲ-1, Ⅲ-2, and Ⅲ-4. Clinical observations from this familial case highlight the importance of early identification and intervention in patients with LVNC to mitigate the risks of heart failure, sudden cardiac death, and thromboembolic events. The MYH7 variant plays a significant role in the pathogenesis of LVNC and may represent a promising target for future gene-based therapies aimed at improving patient outcomes.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: